Evidence map›Paper›PMID 21849528›Full record

ArticleThe Journal of clinical endocrinology and metabolism2011

Treatment of pediatric Graves' disease is associated with excessive weight gain.

Nicole R van Veenendaal, Scott A Rivkees

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06921304 (BASE-DIET), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06921304 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

BASE-DIET: a Randomized Clinical Trial to Examine the Impact of a Dietary-nutritional Intervention on Body Weight Recovery, Metabolic Parameters, and Body Composition in Patients With a New Diagnosis of Graves' Disease

TypeinterventionalSponsorIstituti Clinici Scientifici Maugeri SpARan2024 to 2026Enrolled54ConditionsGraves DiseaseArmsIntensive Lifestyle Intervention
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Change in BMI after radioactive iodine ablation for graves disease.International journal of pediatric endocrinology · 2017
    Article
  6. Pediatric Graves' disease: management in the post-propylthiouracil Era.International journal of pediatric endocrinology · 2014
    Review
  7. Thyroid function and obesity.European thyroid journal · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Nicole R van VeenendaalPediatric Endocrinology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Scott A Rivkees
Yale University · US

Funding

FDA HHS R01FD15186
6 · The paper itself

Abstract

contextLittle information is available about changes in body weight and body mass index in children before, during, and after treatment for Graves' disease (GD).

objectiveOur objective was to examine changes in body weight after treatment for GD in children as related to clinical features.

designThe medical records of 43 pediatric patients with GD [35 girls and eight boys, aged 4.0-18.5 (mean 10.9) yr] were examined. Patients were included if clinical data were available for 1 yr before and after the diagnosis of GD.

main outcome measuresWeight, height, body mass index (BMI) z-scores, and thyroid hormone levels were assessed.

resultsOverall, patients presented with an average BMI z-score of -0.02 ± 1.05 that was not different from the normal population (P = 0.921) or their premorbid values (P = 0.07). However, in the subset of patients who were initially overweight or obese in the premorbid state, the BMI decreased significantly during the development of hyperthyroidism (P < 0.05). After initiation of treatment, patients gained significant amounts of weight over the first 6 months leading to elevated BMI z-scores (P < 0.0001), and elevations in BMI persisted in about 25% of the patients.

conclusionExcessive weight gain within 6 months of treatment is seen in children treated for GD, and the gain in weight can persist.

Indexed as

AdolescentAgingAntithyroid AgentsBody Mass IndexBody WeightChildChild, PreschoolCohort StudiesFemaleGraves DiseaseHumansIodine RadioisotopesMaleMethimazolePropylthiouracilSex CharacteristicsAntithyroid AgentsIodine RadioisotopesMethimazolePropylthiouracilThyroid Hormones

Identifiers

PMID21849528
PMCPMC3200241
OpenAlexW2115160033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.